Ecolab
ECL
$266.88
+1.01%
Ecolab is a global leader in cleaning, sanitation, and water management solutions, serving industries such as industrial manufacturing, hospitality, healthcare, and life sciences. As the dominant player in its category, it differentiates itself through a comprehensive portfolio of products and services, including pest control and infection prevention, and a strong presence in the U.S. market with expanding international reach. The current investor narrative centers on Ecolab's strategic pivot into the high-growth AI data center cooling market, highlighted by its $4.75 billion acquisition of CoolIT, which has sparked debate about the price and timing. Meanwhile, the company continues to deliver steady revenue growth and margin expansion, though the stock has underperformed the broader market over the past year.…
ECL
Ecolab
$266.88
Investment Opinion: Should I buy ECL Today?
Rating: Hold. Ecolab is a high-quality company with dominant market position and consistent growth, but its premium valuation and recent underperformance warrant caution. The analyst consensus is Buy with an average target of $319.40, implying 17.1% upside, but the stock needs catalysts to close the gap.
Supporting Evidence: Revenue grew 10.04% YoY in Q1 2026, gross margin expanded to 43.55%, operating margin reached 15.30%, and free cash flow of $1.87 billion supports dividends and capex. The trailing P/E of 35.81x is above the industry average of 22x, but the forward P/E of 29.16x suggests expected earnings growth. ROE of 21.24% demonstrates strong capital efficiency. The stock's 1-year relative strength of -16.93% vs. the S&P 500 indicates it has lagged, but the 1-month relative strength of +1.09 suggests recent improvement.
Risks & Conditions: The biggest risks are execution of the CoolIT acquisition, valuation compression if growth slows, and macro headwinds. This Hold would upgrade to Buy if the stock pulls back to a P/E below 30x or if CoolIT integration shows clear progress (e.g., revenue contribution exceeding $500 million). It would downgrade to Sell if revenue growth decelerates below 5% or gross margin falls below 40%. Overall, ECL appears fairly valued relative to its history but overvalued vs. peers, making it a hold for now.
Sign up to view all
ECL 12-Month Price Forecast
Ecolab's fundamentals are solid with double-digit revenue growth and expanding margins, but the premium valuation and recent stock underperformance create a balanced risk/reward. The neutral stance reflects the uncertainty around the CoolIT acquisition's impact. If integration proceeds smoothly and margins continue to expand, the stock could re-rate higher. Conversely, any misstep could lead to multiple compression. Key developments to watch include next quarter's earnings (expected in late July 2026) and any updates on CoolIT revenue contribution. An upgrade to bullish would require clear evidence of accelerating growth from AI cooling, while a downgrade to bearish would follow margin deterioration or a significant earnings miss.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Ecolab's 12-month outlook, with a consensus price target around $319.43 and implied upside of +19.7% versus the current price.
Average Target
$319.43
0 analysts
Implied Upside
+19.7%
vs. current price
Analyst Count
—
covering this stock
Price Range
$275 - $345
Analyst target range
Ecolab is covered by 20 analysts, with a consensus recommendation of 'Buy' and a mean recommendation score of 1.73 (where 1 is Strong Buy and 5 is Strong Sell). The average target price is $319.40, implying an upside of 17.1% from the current price of $272.83. The distribution leans bullish, with recent actions including upgrades from UBS (Neutral to Buy) and reaffirmations from Deutsche Bank, RBC Capital, and Citigroup. The target price range spans from a low of $275.00 to a high of $345.00. The high target of $345.00 assumes successful integration of the CoolIT acquisition and acceleration in AI-driven data center cooling demand, while the low target of $275.00 reflects concerns about execution risks and margin pressure. The relatively wide spread of $70 (20% of the average) indicates moderate uncertainty, though the consistent 'Buy' ratings from major firms suggest conviction in the long-term story. The recent upgrade from UBS and steady support from key analysts reinforce a positive sentiment, though the stock's underperformance relative to the market suggests that near-term catalysts are needed to close the gap to the average target.
Bulls vs Bears: ECL Investment Factors
Ecolab presents a mixed picture: strong fundamentals with expanding margins, robust free cash flow, and a dominant market position, but the stock has underperformed the market and trades at a premium valuation. The bull case rests on successful integration of the CoolIT acquisition and continued margin expansion, while the bear case highlights execution risk and valuation vulnerability. Currently, the bull side has slightly stronger evidence given the consistent revenue growth and analyst consensus, but the key tension is whether the CoolIT acquisition will be a growth catalyst or a value-destructive distraction. The resolution of this strategic pivot will most likely determine the stock's trajectory over the next 12 months.
Bullish
- Dominant Market Position with Pricing Power: Ecolab is the global market share leader in cleaning and sanitation products, with a comprehensive portfolio spanning industrial, hospitality, healthcare, and life sciences. This dominance allows for consistent revenue growth, evidenced by Q1 2026 revenue of $4.066 billion, up 10.04% YoY.
- Expanding Margins and Profitability: Gross margin improved from 38.20% in Q1 2023 to 43.55% in Q1 2026, while operating margin expanded from 11.33% to 15.30% over the same period. Net margin of 10.64% is healthy, reflecting operational efficiencies and cost management.
- Strong Free Cash Flow Generation: Free cash flow (TTM) of $1.87 billion provides ample coverage for capital expenditures ($348.5 million in Q1 2026) and dividends ($215.9 million in Q1 2026). The free cash flow yield of approximately 2.5% indicates reasonable cash generation relative to valuation.
- Strategic Pivot to AI Data Center Cooling: The $4.75 billion acquisition of CoolIT positions Ecolab in the high-growth AI data center cooling market. If successful, this could open a new revenue stream and justify the premium valuation, with analyst high target of $345 implying 26.5% upside.
Bearish
- Premium Valuation Leaves No Room for Error: Trailing P/E of 35.81x is 63% above the specialty chemicals industry average of ~22x. While justified by growth, any earnings miss could trigger multiple compression, as the stock already trades near the lower end of its 5-year P/E range (24x-74x).
- Stock Underperformance vs. Market: Over the past year, ECL returned only +1.42% vs. the S&P 500's +18.35%, a relative underperformance of -16.93%. The stock is range-bound at 50.1% of its 52-week range, indicating lack of momentum and market skepticism.
- CoolIT Acquisition Execution Risk: The $4.75 billion acquisition is a bold strategic pivot, but the stock declined on the announcement, suggesting investor skepticism about the price and timing. Integration risks and potential margin dilution could weigh on near-term earnings.
- Moderate Leverage and Interest Expense: Debt-to-equity ratio of 0.97 and interest expense of $72.7 million in Q1 2026 (up from $72.1 million in Q1 2025) indicate moderate leverage. Rising interest rates could increase borrowing costs and pressure margins.
ECL Technical Analysis
Ecolab's stock is in a range-bound consolidation phase, with a 1-year price change of +1.42% significantly lagging the S&P 500's +18.35%. The current price of $272.83 sits at 50.1% of its 52-week range ($243.15 low to $309.27 high), indicating a neutral position—neither overbought nor oversold. This positioning suggests the market is awaiting a catalyst to break out of the sideways pattern, as the stock has failed to sustain momentum near the highs. Short-term momentum shows a mixed picture: the 1-month change of +1.40% slightly outperforms the S&P 500's +0.31%, but the 3-month change of -0.72% contrasts with the index's +4.67%. This divergence implies that while recent buying interest has emerged, the longer-term trend remains weak, and the stock is struggling to gain traction relative to the broader market. The relative strength indicators (1-month RS of 1.09 vs. 1-year RS of -16.93) confirm this short-term improvement against a backdrop of sustained underperformance. Key technical levels are defined by the 52-week low of $243.15 and the 52-week high of $309.27. A breakout above $309.27 would signal a resumption of the uptrend, while a breakdown below $243.15 could trigger further selling. With a beta of 0.895, Ecolab is slightly less volatile than the market, meaning it tends to move less than the S&P 500, which may appeal to risk-averse investors but also limits upside in strong rallies.
Beta
0.90
0.90x market volatility
Max Drawdown
-20.3%
Largest decline past year
52-Week Range
$243-$309
Price range past year
Annual Return
-1.4%
Cumulative gain past year
| Period | ECL Return | S&P 500 |
|---|---|---|
| 1m | -0.9% | +0.4% |
| 3m | -1.7% | +5.5% |
| 6m | -5.3% | +8.4% |
| 1y | -1.4% | +18.9% |
| ytd | +1.6% | +9.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ECL Fundamental Analysis
Ecolab's revenue trajectory remains solidly growth-oriented, with Q1 2026 revenue of $4.066 billion, up 10.04% year-over-year from $3.695 billion in Q1 2025. The multi-quarter trend shows consistent expansion, with revenue growing from $3.985 billion in Q2 2024 to $4.196 billion in Q4 2025. Segment data reveals that Global Water ($2.043 billion) and Global Institutional and Specialty ($1.511 billion) are the primary growth drivers, while Global Life Sciences ($200.9 million) and Global Pest Elimination ($310.8 million) contribute smaller but stable streams. This growth trajectory supports the investment case for a company with pricing power and essential service demand. Profitability is robust, with net income of $432.6 million in Q1 2026 and a gross margin of 43.55%, which has improved from 38.20% in Q1 2023. Operating margin expanded to 15.30% in Q1 2026 from 11.33% in Q1 2023, reflecting operational efficiencies and cost management. The net margin of 10.64% is healthy for the specialty chemicals industry, indicating that Ecolab is effectively converting revenue into profit. The balance sheet shows moderate leverage with a debt-to-equity ratio of 0.97 and a current ratio of 1.08, suggesting adequate liquidity. Free cash flow (TTM) of $1.87 billion provides ample coverage for capital expenditures ($348.5 million in Q1 2026) and dividends ($215.9 million in Q1 2026). Return on equity (ROE) of 21.24% demonstrates strong capital efficiency, while the free cash flow yield of approximately 2.5% (based on market cap) indicates reasonable cash generation relative to valuation.
Quarterly Revenue
$4.1B
2026-03
Revenue YoY Growth
+10.0%
YoY Comparison
Gross Margin
43.5%
Latest Quarter
Free Cash Flow
$1.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ECL Overvalued?
Given Ecolab's positive net income, the primary valuation metric is the P/E ratio. The trailing P/E of 35.81x is elevated compared to the forward P/E of 29.16x, implying the market expects earnings growth to reduce the multiple over the next year. This gap suggests that analysts anticipate continued earnings expansion, which is consistent with the company's growth trajectory. Compared to the specialty chemicals industry average P/E of approximately 22x, Ecolab trades at a 63% premium. This premium is justified by its dominant market position, consistent revenue growth, and expanding margins, but it also leaves little room for error. Historically, Ecolab's trailing P/E has ranged from about 24x to 74x over the past five years. The current 35.81x is near the lower end of this range, suggesting that the stock is not excessively overvalued by its own standards. However, it remains above the historical median, indicating that the market is pricing in above-average growth expectations, which could be vulnerable to disappointment.
PE
35.8x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 25x~56x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
24.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Ecolab's debt-to-equity ratio of 0.97 and interest expense of $72.7 million in Q1 2026 indicate moderate leverage, which could become burdensome if interest rates remain elevated. The company's net margin of 10.64% is healthy but could be pressured by integration costs from the $4.75 billion CoolIT acquisition. Free cash flow of $1.87 billion provides a cushion, but any disruption in revenue growth or margin expansion could strain the balance sheet. The current ratio of 1.08 suggests adequate but not ample liquidity, leaving limited room for error in working capital management.
Market & Competitive Risks: Ecolab's trailing P/E of 35.81x is a 63% premium to the industry average, making it vulnerable to valuation compression if growth disappoints. The stock's beta of 0.895 indicates lower market correlation, but its 1-year relative strength of -16.93% vs. the S&P 500 shows persistent underperformance. The CoolIT acquisition faces competitive risks from established data center cooling providers, and any regulatory hurdles could delay expected synergies. Additionally, the stock's range-bound technical pattern suggests the market is awaiting a catalyst to break out.
Worst-Case Scenario: If the CoolIT acquisition fails to deliver expected synergies, revenue growth decelerates below 5%, and margins contract due to integration costs, the stock could fall to its 52-week low of $243.15, representing a -10.9% decline from the current price of $272.83. In a severe recession with broad market sell-off, the stock could test lower levels, potentially reaching the analyst low target of $275.00 (already near current price) or below. The maximum drawdown over the past year was -20.31%, implying a potential loss of up to 20% from current levels in an adverse scenario.
FAQ
The key risks are: 1) Execution risk from the $4.75 billion CoolIT acquisition, which could pressure margins and delay expected synergies. 2) Valuation risk: the trailing P/E of 35.81x leaves little room for error; any earnings miss could trigger multiple compression. 3) Macro risk: with a beta of 0.895, ECL is less volatile than the market but still sensitive to economic downturns that could reduce demand for cleaning and sanitation services. 4) Competitive risk: new entrants in AI data center cooling could challenge CoolIT's market share. The most severe risk is a failed integration leading to a -10.9% decline to the 52-week low of $243.15.
The 12-month forecast is mixed: the bull case (25% probability) sees the stock reaching $310-$345, driven by successful CoolIT integration and margin expansion. The base case (50% probability) targets $290-$320, with steady growth and gradual margin improvement, aligning with the analyst average target of $319.40. The bear case (25% probability) sees the stock falling to $245-$275, if integration fails or growth decelerates. The most likely scenario is the base case, assuming revenue growth of 8-10% and stable margins. Key catalysts include the next earnings report and updates on CoolIT revenue contribution.
ECL's trailing P/E of 35.81x is 63% above the specialty chemicals industry average of ~22x, suggesting it is overvalued relative to peers. However, compared to its own 5-year history (range 24x-74x), the current multiple is near the lower end, indicating it is not excessively overvalued by its own standards. The forward P/E of 29.16x implies the market expects earnings growth to reduce the multiple. The premium is justified by Ecolab's dominant market position, consistent revenue growth (10% YoY), and expanding margins. Overall, ECL is fairly valued relative to its growth trajectory but expensive vs. the industry, meaning investors are paying a premium for quality and stability.
ECL is a good stock to buy for long-term investors seeking a high-quality company with dominant market position and consistent growth, but the premium valuation (trailing P/E of 35.81x vs. industry 22x) means it is not a bargain. The analyst consensus is Buy with an average target of $319.40, implying 17.1% upside, but the stock has underperformed the market over the past year. The biggest downside risk is execution of the CoolIT acquisition; if it succeeds, the stock could re-rate higher. For risk-tolerant investors with a 3-5 year horizon, ECL offers a compelling risk/reward, but near-term volatility is likely. It is less suitable for short-term traders given the range-bound technicals.
ECL is better suited for long-term investment due to its stable growth, dominant market position, and moderate beta of 0.895. The stock's range-bound technicals and recent underperformance make it less attractive for short-term trading, as catalysts are needed to break out. The dividend yield of 1.01% and payout ratio of 36.3% provide income for long-term holders. A minimum holding period of 3-5 years is recommended to allow the CoolIT acquisition to mature and margin expansion to materialize. Short-term traders may find limited opportunities given the low volatility and lack of momentum.